Back to Search Start Over

Implantation of the Black Artisan Iris-Claw Intraocular Lens: A Case Series.

Authors :
Demirkaya N
Vasanthananthan K
van der Meulen I
Lapid-Gortzak R
Source :
Case reports in ophthalmology [Case Rep Ophthalmol] 2020 Oct 30; Vol. 11 (3), pp. 553-560. Date of Electronic Publication: 2020 Oct 30 (Print Publication: 2020).
Publication Year :
2020

Abstract

In this case series, we report the use of the black Artisan iris-claw intraocular lens (IOL) (Ophtec, The Netherlands) in 6 patients with various visually debilitating symptoms requesting occlusion of one eye. Between 2016 and 2019, 6 (5 female, 1 male) patients underwent implantation of the custom-made black Artisan iris-claw IOL after other management strategies had failed to relieve their symptoms. The black Artisan IOL is an opaque anterior chamber IOL that is fixated to the iris by enclavation. Data were obtained from the electronic patient records (Epic, Verona, WI, USA). All implantation surgeries were uneventful. In terms of outcomes, 4 patients (67%) were satisfied with the result. In 2 patients (33%), the dysphotopic symptoms were not resolved, and these patients opted for either an enucleation or an evisceration. In conclusion, a black Artisan IOL is a valuable and - if needed - reversible option in the management of patients suffering from monocular debilitating visual symptoms leading to disturbances of binocular vision. The clinical presentation leading to the implantation of a pupil-occluding IOL varies and patient satisfaction following implantation is variable. Careful preoperative evaluation of patient factors and expectations, and stepped-care management is recommended to minimize treatment failure. Pupil-occluding lens implantation is often the last step in the treatment of intractable visual complaints in eyes with complex ophthalmologic history, before evisceration or enucleation.<br />Competing Interests: Ruth Lapid-Gortzak: Alcon: consulting, speaker bureau member, research funding; Eye Med: consulting; Eye Yon: consulting, research funding; Hanita lenses: consulting, speaker bureau member; Sanoculis: consulting; Santen: consulting; Thea Pharma: consulting, speaker bureau member; VSY Biotechnology: speaker bureau member. The other authors have no financial disclosures to make.<br /> (Copyright © 2020 by S. Karger AG, Basel.)

Details

Language :
English
ISSN :
1663-2699
Volume :
11
Issue :
3
Database :
MEDLINE
Journal :
Case reports in ophthalmology
Publication Type :
Academic Journal
Accession number :
33250756
Full Text :
https://doi.org/10.1159/000509528